Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders

Keyphrases

• Neurodevelopmental Disorders 100%
• Central Nervous System 100%
• Neurodegenerative Diseases 100%
• Nose-to-brain Drug Delivery 100%
• Polymeric Nanocarriers 100%
• Neurodevelopmental Conditions 66%
• Blood-brain Barrier 66%
• Nano-drug Delivery System 66%
• Neurodegenerative Conditions 66%
• Intranasal 66%
• Autism Spectrum Disorder 33%
• Attention Deficit Hyperactivity Disorder 33%
• Intellectual Disability 33%
• Nanoparticles 33%
• Neurodevelopmental 33%
• Nasal mucosa 33%
• Progressive Conditions 33%
• Fluid Barrier 33%
• Drug Bioavailability 33%
• System Status 33%
• Systemic Circulation 33%
• Brain Bioavailability 33%
• Polymeric Nanoparticles 33%
• Nose-to-brain Delivery 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Degenerative Disease 100%
• Bioavailability 100%
• Nanocarrier 100%
• Nanoparticle 100%
• Autism 50%
• Attention Deficit Disorder 50%
• Intellectual Impairment 50%
• Drug Delivery System 50%
• Systemic Circulation 50%

Neuroscience

• Central Nervous System 100%
• Neurodegenerative Disorder 100%
• Nose 100%
• Nanocarriers 100%
• Blood Brain Barrier 66%
• Pervasive Developmental Disorder 33%
• Attention Deficit Hyperactivity Disorder 33%
• Nose Mucosa 33%